Comunicati.net - Comunicati pubblicati - Istituzioni Comunicati.net - Comunicati pubblicati - Istituzioni Wed, 20 Jan 2021 02:29:17 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://prwww.comunicati.net/comunicati/istituzioni/1 «Il mondo salvato dai ragazzini». Un progetto di Reading Literacy nel dossier Procida 2022 Tue, 19 Jan 2021 03:38:22 +0100 http://prwww.comunicati.net/comunicati/istituzioni/varie/684078.html http://prwww.comunicati.net/comunicati/istituzioni/varie/684078.html Simona Pasquale Simona Pasquale

Il mondo salvato dai ragazzini (e dai libri): perché la cultura non Isola! 

L’innovativo progetto di Reading Literacy tra le proposte vincenti del dossier Procida Capitale Italiana per la Cultura 2022

NAPOLI �“ Procida Capitale Italiana della Cultura 2022. È ufficiale, la commissione tecnica “assolutamente impenetrabile e indipendente” voluta dal MiBACT e presieduta dal prof. Stefano Baia Curioni, docente di Storia Economica dell’Università Bocconi di Milano, ha scelto l’isola del Golfo di Napoli come porta bandiera nazionale di quello che lo stesso Ministro per i Beni e le Attività Culturali e il Turismo, Dario Francescini, ha definito l’anno della Ripartenza e della Rinascita.  Prima isola a candidarsi da quando è stata inaugurata l’iniziativa nel 2014, Procida ha saputo sbaragliare la concorrenza di Ancona, Bari, Cerveteri (Roma), L’Aquila, Pieve di Soligo (Treviso), Taranto, Trapani, Verbania, Volterra grazie alla forza progettuale di un dossier - curato da Agostino Riitano, già Direttore del comitato promotore di Matera Capitale Europea della Cultura 2019 �“ partecipato dal basso che nelle sue linee guida di sostegno pubblico-privato e inclusività può rappresentare un elemento di discontinuità nel territorio e rappresentare un modello per i processi sostenibili, con un’impronta poetica.

Cultura al centro della propria idea di sviluppo e di apertura verso l’altro, testimoniata dallo slogan «La cultura non isola» che tra gli innumerevoli fiori all’occhiello �“ 44 progetti culturali, 330 giorni di eventi 240 artisti coinvolti e 8 spazi culturali rigenerati �“ che ne prevede uno, in particolare, a misura dei cittadini più giovani, come gli oltre mille bambini e ragazzi coinvolti negli ultimi anni nel progetto «Il mondo salvato dai ragazzini», percorso culturale, formativo e sociale di Reading Literacy ideato e curato dall’Associazione Culturale Kolibrì Napoli per l’Amministrazione comunale di Procida (in collaborazione, tra gli altri, con la storica rivista Andersen�“Il mondo dell’infanzia e Agita Teatro, ente nazionale di formazione riconosciuto dal MIUR). «È una bellissima vittoria collettiva, che premia la progettualità visionaria in un sistema di coesione comunitaria, ma soprattutto riscatta la cultura dei “piccoli”, in senso metaforico e reale: è il morantiano mondo salvato dai ragazzini, ma anche dalla bellezza dei sognatori, dei poeti, degli artisti, degli educatori» commenta all’indomani della proclamazione Donatella Trotta, Presidente dell’Associazione Kolibrì.

Il progetto di ispirazione morantiana, che evoca l’omonimo manifesto poetico-profetico (e politico) scritto da Elsa Morante nel ’68, rappresenta, infatti, un progetto innovativo di educazione precoce alla lettura che, dal 2017, coinvolge l’intera comunità educante dell’isola di Procida - hortus conclusus naturale e luogo d’elezione della scrittrice - in un processo di trasformazione dal basso che ha coinvolto per tre anni di seguito partner eccellenti come la Regione Campania, la Fondazione Banco Napoli per l’Assistenza all’Infanzia, la Fondazione Premio Napoli e l’Università Suor Orsola Benincasa, accanto all’intera comunità dell’Isola flegrea �“ l’Assessorato alla Cultura del Comune, Marina di Procida Spa, gli istituti scolastici IC.1°CD.Capraro e II.SS.Caracciolo-da Procida, l’Associazione culturale Isola di Graziella, la Biblioteca Comunale “Don Michele Ambrosino”, le due librerie dell’Isola, Graziella e Nutrimenti e gemellaggi simbolici con altre realtà italiane �“ e che nel 2018/2019 si è estesa alla terraferma coinvolgendo un’ampia rete di Napoli e provincia, abbracciando centro e periferia. «Pur nella ristrettezza dei finanziamenti pubblici abbiamo sempre creduto nel valore di progetti come questo, rivolto ai ragazzi e a stimolare la loro partecipazione attiva �“ sottolinea il Sindaco Dino Ambrosino �“ Il lavoro continuativo di sensibilizzazione rivolto alla comunità educante che questo progetto porta avanti è molto importante, ed ha rappresentato un originale elemento di novità tra gli altri, contribuendo al successo per la prima volta di un piccolo borgo».

«Questa vittoria rappresenta il coronamento di un sogno che parte da lontano, in cui la cultura occupa un ruolo centrale all’interno del processo di rinnovamento e crescita culturale e un’inversione di tendenza in tema di investimenti per i centri piccoli �“ commenta Nico Granito, ex Assessore alla Cultura �“. Il Mondo salvato dai ragazzini rappresenta la sfida più lungimirante, in cui i giovanissimi sono il presupposto per creare durature condizioni di sviluppo sostenibile. Gli eventi sono effimeri, mentre la cura di una nuova sensibilità nei più piccoli è uno dei mattoni su cui poter costruire la “capitale della cultura” sempre, non solo per un anno». Gli fa eco il neo Assessore alla Cultura, Michele Assante del Leccese: «Tutto quello che abbiamo fatto e facciamo è per le generazioni future. Crediamo nei nostri ragazzi e questo progetto ne è la prova tangibile» sottolinea.  Un progetto incentrato sulla disseminazione di buone pratiche legate a quella che Gianni Rodari definiva «la civiltà dell’infanzia» e un cammino di avvicinamento alla filiera del libro specializzato per ragazzi �“ unico ramo editoriale che in Italia fa registrare un costante segno positivo nelle vendite �“ articolato su tre momenti fondamentali: formazione dei formatori, ossia dei docenti dalla materna alle Superiori, che ricevono crediti formativi riconosciuti dal Ministero dell’Istruzione; incontri ravvicinati d’autore: seminari con gli scrittori per ragazzi afferenti ad una quaterna scelta anno per anno; e attività di laboratorio  con i ragazzi delle scuole, con operatori ed educatori specializzati, tutor di rielaborazione creat(t)ive della pagina scritta attraverso tutti i linguaggi della creatività. Un’esperienza a cui ha partecipato in questi anni, la Vicepreside dell’IC.Capraro Pina Cucurullo: «penso che Procida capitale italiana della cultura 2022 sia il frutto di un'idea condivisa già sperimentata in alcune forme di lavoro, che costituisce la visione moderna dell'isola da realizzare con la partecipazione e la consapevolezza dei cittadini».

L’edizione 2020/21, nel suo percorso formativo realizzato grazie al finanziamento del CEPELL �“ Centro per la Lettura e i Libro del MiBACT, ha saputo fino ad ora cogliere con successo la sfida della trasposizione a distanza, su piattaforma ZOOM, di attività che in origine si svolgevano tutte in sperimentando costantemente nuove modalità di coinvolgimento, confronto e formazione per una “socializzazione a distanza” che vede ancora come partner eccellente, in questa fase, l’Università Suor Orsola Benincasa con la prof.ssa Paola Villani in veste di formatrice  e, tra gli allievi, oltre 60 studenti dei Corsi di Studio in Scienze della Formazione e Beni Culturali, in un fitto calendario di incontri d’autore, Focus Group con Feed Back partecipati, webinar e laboratori nelle scuole intitolato, non a caso: «Educ/azione alla libertà: il mondo salvato dai ragazzini (e dai libri)».

Ufficio stampa: Simona Pasquale, 339.5098790-334.3224441 (Whatsapp) �“ Email: simona.pasquale@gmail.com

]]>
The Bioabsorbable Implants Market To Move Away From Stagnation, Reach US$ XX Million Mon, 18 Jan 2021 10:45:16 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683956.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683956.html persistencemarketresearch persistencemarketresearch Technological improvements and preferences in  bioabsorbable Implants  in recent decades have resulted in wide range of applications and better outcomes which are predicted to contribute to the growth of global bioabsorbable Implants. The launch of new products in the market, brings in new technology which eases treatment procedures and provides improved results to patients.

Manufacturers on a global level are engaging in developing products which should get recognition in order to be in use. Bioresorbable implants have been used for the fixation of facial bones offering various advantages over titanium plates by reducing the need for a second operation for their removal.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/28057

Company Profiles:

  • Meryl Life Sciences Pvt. Ltd.
  • Medtronic Plc
  • Smith & Nephew Plc
  • Stryker Corporation
  • Wright Medical Group
  • KLS Martin
  • BIOTRONIK Ltd
  • Syntellix AG
  • Q3 Medical Devices Limited.
  • JW Medical Systems LTD
  • ORBUSNEICH MEDICAL.

Bioabsorbable implants are used for treating, knee hands, and wrist injuries moreover the bioabslorbable implants are used successfully in reconstruction and repair of many extra and intra articular abnormalities in the shoulders such as rotator cuff tears.

Also bioabsorbable implants are used for spinal reconstruction surgeries, for instance PLA screws are used for fusion procedures and cervical decompression. PLLA pins are used in lumbar spine which improve the mobility.

Significant collaboration efforts among key players in the medical industry, and presence of reimbursement agencies will further aid the growth of the market. Owing to the dissolving nature of the bioabsorbable implants and faster results, the bioabsorbable implants space has been witnessing modest growth in recent years.

Get To Know Methodology of Report @  https://www.persistencemarketresearch.com/methodology/28057

Increasing prevalence of patients suffering from osteoarthritis leading to knee fracture, among the population is increasing the growth of bioabsorbable Implants market. Almost 260,000 Americans suffer and require surgeries. Presence of large patient pool suffering from Pelvic organ prolapse is expected to drive the growth of the transvaginal Bioabsorbable Implants and meshes in the market during the forecast period.

The bioabsorbable Implant companies are significantly collaborating and acquiring among the key players in the industry, reimbursement agencies are further aiding the growth of the market. The company DePuy Synthes Acquired Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects with which the company is aiming to create patient-specific, bioresorbable implants

Bioabsorbable Implants market is fragmented in nature with the distributors of the b ioabsorbable Implants market in different parts of the world. The bioabsorbable implants companies operating in the market are focusing on launching better and advanced products to further increase sensitivity and better outcomes to avoid side effects which would further increase the adoption rate of the bioabsorbable implants in the future.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/28057

However, side effects and complications such as allergies, inflammations, drug reactions resulting in organ and system failure is expected to negatively impact the growth of the global Bioabsorbable Implants market over the forecast period.

According to the report, the fixation devices implants accounted for over 40% revenue share in the global bioabsorbable Implants market in 2017.

Moreover, the advancements in the technology is creating awareness and popularity of Bioabsorbable Implants in the market which is further increasing, the growth of other segment of Bioabsorbable Implants in the near future.

]]>
The Fibrinogen Testing Market To Witness A Stunning Progression, Reach US$ XX Million Mon, 18 Jan 2021 10:44:54 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683955.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683955.html persistencemarketresearch persistencemarketresearch The fibrinogen testing reagents market observes a dynamic nature of consumer preference for each product as part of their operating instrument. Though, there have been no significant technological advancements in the development of reagents since many years now. The applications and usage still remain the same, but the influx of new manufacturers in the fibrinogen testing reagents market surely assures a much more competitive market space than it currently is.

There are several factors for the fibrinogen testing reagents market to grow in the coming years, as bleeding conditions in the US, followed by India and China, are expected to contribute to the largest consumer base for fibrinogen testing reagents.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/5420

Company Profiles:

  • Thermo Fisher Scientific Inc.
  • Grifols
  • Helena Laboratories Corporation
  • Stago
  • TULIP DIAGNOSTICS (P) LTD
  • Werfen
  • Biosystems S.A.
  • Randox Laboratories Ltd.
  • Technoclone
  • Medirox AB
  • MedTest
  • Enzyme Research Laboratories(r2 Diagnostics)
  • Kamiya biomedical Company
  • Pathway Diagnostics Limited

According to the latest research by PMR, the global fibrinogen testing reagents market is estimated to have accounted for US$ 116.3 Mn in terms of value during 2017. The report on the fibrinogen testing reagents market further projects that, the market is likely to grow at a CAGR of 8.9% during the forecast period 2018-2028.

Rising Preference for the Convenience of Online Services Favoring Sales of Fibrinogen Testing Reagents

An increase in the online sale of products and ordering of online tests have positively impacted the growth of the global fibrinogen testing reagents market. Several laboratories offer online services, wherein, patients can order their desired tests, while the testing is taken care of by a laboratory. The adoption rate of online services is higher in countries such as the UK and the US. Such differences lead to a better market space for fibrinogen testing reagents.

Also, a rise in the awareness among people about blood condition diseases has led to an increase in acceptance of disposable products. Parallel influences of diagnostic consumables have a positive impact on the overall fibrinogen testing reagents market.

The fibrinogen kits segment is the leading segment in terms of revenue, by reagent type, in the fibrinogen testing reagents market, registering a 71.4% revenue share in 2017. After fibrinogen kits, the multifibren U reagents and omidazole buffer kits are expected to follow in the fibrinogen testing reagents market, by reagent type.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/5420

Fibrinogen testing reagents are most widely used for the diagnosis of end-stage liver disease. The end-stage liver disease segment, by indication, is thus expected to dominate the fibrinogen testing reagents market in term of revenue over the forecast period of 2018-2028. Among all end users in the fibrinogen testing reagents market, the hospitals segment is the most lucrative segment, and this is followed by the diagnostic laboratories segment.

East Asia Likely to Emerge Lucrative for Fibrinogen Testing Reagents Market

While Europe has been a prominent regional market for fibrinogen testing reagents, followed by North America, the former will maintain a significant revenue share of nearly a third of the fibrinogen testing reagents market. and is estimated to have registered a revenue share of 31.4% in 2017.

The report has cited East Asia as an attractive region for fibrinogen testing reagents market players. South Korea, South Africa, and Russia are some of the lucrative countries reflecting high growth potential for the fibrinogen testing reagents market, according to the report. South Korea has been projected as one of the fastest thriving markets for the global fibrinogen testing reagents.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/5420

Leading Players in Fibrinogen Testing Reagents Market Strategizing on Expansion in Emerging Regions

A majority of key players are reportedly focusing on increasing their shares in South Asian and Latin American markets for fibrinogen testing reagents via strategic mergers and acquisitions involving recognized regional players and investment groups. On the other hand, regional players in the fibrinogen testing reagents market are focusing on entering long-term contractual relationships with direct end users to be able to sustain continuous revenue flow.

]]>
The Cardiac Marker Analyzer Market To Slither Amidst Covid-19, To Pick Up Pace Post-Covid-19, Reach US$ XX Million Mon, 18 Jan 2021 10:44:31 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683954.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683954.html persistencemarketresearch persistencemarketresearch Global demand for cardiac marker analyzers is projected to witness  over 4.5% year  on year growth in 2019. As indicated by Persistence Market Research in a newly published research intelligence study, North America remains the top consumer market for cardiac marker analyzers manufacturers, and the region's market value is projected to cross  US $ 285 million in 2019 .

Expanding Geriatric Population and Obesity

Nearly 17% of the global population will be above 65 years of age by the end of 2050, as projected by NIH (National Institutes of Health). Whereas, WHO (World Health Organization) indicates that around 13% of the worldwide population is currently suffering from obesity. While both the aforementioned factors intersect at a higher risk of acquiring cardiovascular diseases, it is more likely that the adoption of cardiac market analyzers will be on the rise in coming years.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3479

Company Profiles

  • Siemens AG
  • Radiometer Medical
  • Abbott Laboratories
  • Quidel Corporation
  • Beckman Coulter, Inc.
  • Boditech Med Inc.
  • F. Hoffmann-La Roche Ltd
  • Creative Diagnostics
  • Others.

Disease Management

The growing need for early detection of rapidly prevailing CVDs such as myocardial infarction and angina pectoris is likely to push prospects for cardiac marker analyzers in the near future. A rising trend of individualized treatment and real-time results targeting early patient diagnostics is playing a crucial role popularizing the demand for cardiac marker analyzers.

With ascending significance of disease management, the devices that help manage the disease progression rate are gathering significant momentum in recent years – subsequently encouraging sales of cardiac marker analyzers.

Laboratory diagnostics are identified to hold promising opportunities for manufacturers based on developing economies such as India, China, Brazil, and Japan. These emerging markets are projected to remain highly attractive owing to the briskly progressing R&D platform.

Drug Development Related Opportunities

Growing use of cardiac marker analyzers in drug development as well as lab diagnostics continues to stimulate innovation and adoption, indicates the report.

“Visibly growing preference for Troponin over other conventional markers in diagnosis of heart attack is the key trend shaping the revenue growth of cardiac marker analyzers landscape,” explains the analyst at the company. Adding further, “The remarkable inadequacy in existing drug development processes for CVDs is another strong factor broadening the scope for penetration of cardiac marker analyzers at a global level,” says the analyst.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3479

Competition Tracking

While around 80% share of the global revenue through sales of cardiac marker analyzers belongs to the top industry players, the rest is covered by a number of smaller companies that currently operate at a local or regional level. Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Siemens AG, and a few others are thoroughly profiled in the PMR report.

Abbott acquired St. Jude Medical the last year, with an objective to reap benefits of the latter's strong global position in thriving cardiac areas such as heart failure, atrial fibrillation, structural heart, and chronic pain complement.

Earlier this year, Beckman Coulter Inc. (Danaher Corporation) received the clearance approval by Health Canada for the new high-sensitivity troponin (hsTnI) assay. More recently, Siemens AG launched the Troponin test kit that has been a key marker used diagnosing heart attack.

Besides M&A, strategic collaborations with local distributors, suppliers, wholesalers, and retailers is also likely to remain one of the key strategies of competitors in cardiac marker analyzers landscape. Several leading companies are also signing contractual agreements with channel partners such as associations and universities over the manufacturing of cardiac market test kits.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3479

North America and Europe Remain Top Markets

At an estimated 5% yearly growth in 2019, North America remains the top performing market for cardiac marker analyzers. While chemiluminiscence immunoassay (CLIA) analyzers account for more than 30% share of the region's total revenue, whereas diagnostic centers continue to make up for over half of the market value of the region. Enzymeimmunoassay (EIA) analyzers are however projected for highly attractive investment opportunities in coming years.

Europe's market, the second largest consumer of cardiac marker analyzers, is predominantly driven by chemiluminiscence immunoassay (CLIA) analyzers, followed by MICA analyzers ie presumably the most lucrative segment for key players.

]]>
The Confocal Microscope Market To Show Constructive Disruption With US$ 1,310.5 Million Mon, 18 Jan 2021 10:44:09 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683953.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683953.html persistencemarketresearch persistencemarketresearch According to the latest market report published by Persistence Market Research titled 'Global Confocal Microscope Market: Global Industry Analysis 2013 - 2017 and Forecast, 2018 - 2028,' the global confocal microscope market is projected to reach  US $ 1,310.5 Mn  by the end of  2028  and grow at a  CAGR of 3.3%  during the forecast period.

Global Confocal Microscope Market: Dynamics

Confocal microscope is a special form of standard fluorescence microscope. Confocal microscopy is different from the conventional wide field fluorescence microscopy, in which the optical path is designed to place in front of the image detector (photomultiplier tube or camera), and an aperture (opening) at a point where the image is focused in conjunction with the focal plane of the image.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/16174

Company Profiles

  • Olympus Corporation
  • Leica Microsystem (Sub. Danaher)
  • ZEISS Group (Carl Zeiss Meditec AG)
  • Nikon Corporation
  • Bruker Corporation
  • Bio-Rad Laboratories, Inc
  • Oxford Instruments plc
  • Thorlabs, Inc.
  • Confocal.nl
  • ISS.Inc
  • Others.

Government policies and funding for biological research activities and shift towards value-based care are the major factors expected to drive the growth of the market for confocal microscope over the forecast period.

Furthermore, increasing number of research and development activities and technological advancement in microscopy are the other factors expected to spur the growth of the market for confocal microscope over the forecast period.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/16174

Increasing spending on research & development and emergence of academia as the primary organization for carrying out basic research will further increase the adoption rate of confocal microscope. Likewise, use of confocal microscope for live cell imaging and confocal microscopy in ophthalmology is also expected to drive the growth of the market for confocal microscope.

However, high cost of technologically advanced microscopes and shortage of skilled professionals and expertise are expected to hamper the growth of the Confocal Microscope market.

Global Confocal Microscope Market: Forecast

The global confocal microscope market is segmented on the basis of product type, and end user. On the basis of product type, the global confocal microscope market is segmented into microscope system, accessories and software. Microscope system is sub segmented into laser scanning confocal microscope, spinning disk confocal microscope and re scan microscope.

The microscope systems is expected to be the leading segment in the global confocal microscope market over the forecast period. The microscope systems accounts a total value share of 92.0% of the global confocal microscope market in 2017. The laser scanning confocal microscope segment is estimated to have incremental opportunity of US $ 200.1 Mn between 2016 and 2028.

Among end user, academic & research institute segment is expected to hold high share in the global confocal microscope market owing to increasing number of research in life science applications and rising adoption of confocal microscope in academic research.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/16174

Geographically, the global confocal microscope market has been segmented into North America, Latin America, Europe, Asia Pacific, Japan and Middle East & Africa. This report assesses the trends driving the growth of each segment and offers analysis and insights into the potential of the confocal microscope market in specific regions.

North America accounted a large share in the global market in 2017, and is expected to be the dominant regional market for confocal microscope over the forecast period, owing to increasing spending in research and development.

Besides, the presence of several key players with a robust distribution network for microscope and collaboration for the development of new techniques are some of the other key factors expected to drive the growth of the confocal microscope market in North America. Asia Pacific is expected to witness rapid growth over the forecast period.

]]>
The Humanized Liver Mice Model Market To Flicker Amidst Covid-19, Reach US$ 22.8 Million Mon, 18 Jan 2021 10:43:46 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683952.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683952.html persistencemarketresearch persistencemarketresearch A large number of humanized liver mice models are available, including uPA-SCID mice, FRG KO mice, and TK-NOG mice, among others. Factors such as increasing incidence of liver cirrhosis, technological advancement and development of new humanized liver mice models, increase in number of FDA approvals for liver-based disease treatment dugs have increased the number of research and development activities, which require these models.

However, the high cost of mice models as well as high shipping cost, and availability of alternatives are factors expected to hinder the growth of the humanized liver mice model market during the forecast period. Furthermore, regulatory challenges including patenting of mice and other ethical issues including the use of 3Rs policy are also expected to restrain the growth of the humanized liver mice model market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25417

Company Profiles

  • Taconic Biosciences, Inc.
  • Beijing Vitalstar Biotechnology Co., Ltd.
  • Yecuris Corporation
  • PhoenixBio Group
  • In-Vivo Science Inc.
  • The Jackson Laboratory
  • University of Massachusetts Medical School(Mueller Lab)
  • Oncodesign
  • University of Nebraska Medical Center
  • Others.

The global humanized liver mice model market is projected to account for over US$ 22.8 Mn in terms of value by 2026 end, according to a latest research by PMR. The report on the global humanized liver mice model market further projects significant growth potential with average year-on-year growth rate of 4.6% through 2026.

Albumin enhancer/promoter-driven urokinase-type plasminogen and activator/severe combined immunedeficient mice are known as the uPA-SCID mice. These mice suffer from a transgene-induced liver disease, and are transplanted with primary human hepatocytes immediately after birth.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25417

These mice were one of the first humanized liver mice model developed with high chimerism and are the most common type of humanized liver mice models available. The TK-NOG mice are designed to express a Herpes Simplex Virus-1 Thymidine Kinase (HSVtk) transgene that is primarily driven by the albumin enhancer/promoter in the liver of the mice. This induces liver-specific injury when treated with gancyclovir.

Human liver cells are then introduced into the liver of the mouse to replace the liver cells that are destroyed. The other type of humanized liver mice model that is gaining popularity is the FRG KO mice. The FRG KO mice are developed by knocking out three genes including Fah-/-; Rag2-/-; and Il2rg-/-.

These mice overcome some of the drawbacks of the uPA-SCID mice such a low breeding capacity and genotype reversion. These mice have a slightly better breeding capacity and cannot undergo genotype reversion allowing the human hepatocytes to be serially transplanted into other mice. These humanized liver mice models also show high chimerism like the uPA-SCID mice.

PMR has segmented the global humanized liver mice model market based on model, application, end user and region. The humanized liver mice model by model is further sub-segmented into uPA-SCID Mice, FRG KO Mice, TK-NOG Mice, and other models. Based on end users, the humanized liver mice model market is segmented into pharmaceutical companies, biotechnology companies, CRO's and academic & research institutes.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/25417

CRO's segment is expected to hold maximum share in the global humanized liver mice model market followed by academic & research institutes segment. Based on application, the humanized liver mice model market is segmented into pharmacokinetic studies, in-vivo liver toxicity testing, drug metabolism studies, and other applications.

North America is expected to be the dominant regional market for humanized liver mice model. This is due to the support for research activities by the government as well as private sectors.

Government funding and support for patenting genetically modified mice are other factors that support the growth of the humanized liver mice model market in North America. China is also expected to be a lucrative regional market for humanized liver mice model due to the changing regulations of the government to support the pharmaceutical and biopharmaceutical industries in the region.

]]>
The Sarcopenia Treatment Market To Witness A Slump, Reach Merely US$ 3,302.0 Million Mon, 18 Jan 2021 10:43:24 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683951.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683951.html persistencemarketresearch persistencemarketresearch According to the latest market report published by the company titled ' Sarcopenia Treatment Market : Global Industry Analysis 2013 - 2017 and Forecast, 2018 - 2026,' the global sarcopenia treatment market is projected to reach  US $ 3,302.0 Mn  by the  end of 2026  and grow at a  CAGR of 4.2%  during the forecast period.

Global Sarcopenia Treatment Market: Dynamics

Sarcopenia is categorized by progressive and generalized loss of skeletal muscle mass and strength, with a risk of adverse outcomes such as poor quality of life, physical disability and death. Sarcopenia is the age-related loss of muscle mass, after the age of 60 the muscle mass declines at an annual rate of 1.5% to 3.0% per year. The prevalence of sarcopenia among people aged 65 years and above is estimated to be 15%, whereas 50% among people aged 80 and above.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/15694

Company Profiles

  • Abbott Laborites
  • Pfizer Inc.
  • Novartis AG
  • GlaxoSmithKline Plc.
  • Nestlé S.A.
  • Bayer AG
  • Sanofi S.A.
  • Amway
  • Cadila Healthcare Ltd.
  • Eli Lilly and Company
  • Others.

Increasing consumption of dietary and nutritional supplements due to health consciousness among the elderly population is expected to propel the demand for sarcopenia treatment. The benefits of nutritional supplements to overcome vitamin deficiency is expected to boost the growth of the sarcopenia treatment market.

Most of the pharmaceutical and food-processing companies are investing in the development of new nutrition supplements in order to focus on the specific needs. Likewise, increasing investments in nutraceutical development is the major factor expected to spur the growth of the sarcopenia treatment market.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/15694

The growth of the sarcopenia treatment market is primary driven by the increasing aging population. According to the National Institutes of Health (NIH), the global population of people aged 80 and above is expected to grow from 126.5 million to 446.6 million between 2015 and 2050.

Reduction of hormone secretion rate and increasing vitamin deficiency with aging are expected to create high demand for sarcopenia treatment supplements. Economic factors such as the rise in consumer spending by the aging population and increasing per capita healthcare expenditure are also expected to drive the demand for sarcopenia treatment supplements.

According to the National Health Expenditure Accounts (NHEA), the U.S. health care spending grew by 4.3% in 2016, reaching US$ 3.3 trillion or US$ 10,348 per person.

However, the diagnosis rate of sarcopenia is very low as a large number of people ignore the symptoms of muscle loss. Moreover, low awareness regarding diagnostic and management methods of sarcopenia due to lack of skilled professionals is expected to hamper the growth of the sarcopenia treatment market.

Moreover, unavailability of sarcopenia treatment drugs and the high cost of protein supplement are the other factors expected to restrain the growth of the sarcopenia treatment market.

Global Sarcopenia Treatment Market: Forecast

The global sarcopenia treatment market is segmented based on treatment type, distribution channel, and region. Based on treatment type, the global sarcopenia treatment market is segmented into protein supplement, vitamin D & calcium supplement, and vitamin B12 supplement.

The protein supplement segment is expected to represent a high revenue share in the global sarcopenia treatment market over the forecast period.

Based on the distribution channel, the global sarcopenia treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and hypermarket & supermarket. Among all the distribution channels, the retail pharmacies is expected to be the leading segment in the global sarcopenia treatment market over the forecast period.

The online pharmacies segment is expected to represent a high growth rate in the global sarcopenia treatment market due to increasing online purchasing and manufacturer's inclination towards digital platforms for marketing and sale.

On the basis of region, the global sarcopenia treatment market has been segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

This report assesses the trends driving the growth of each segment and offers analysis and insights into the potential of the sarcopenia treatment in specific regions. North America is expected to contribute a high revenue share in the global sarcopenia treatment market over the forecast period.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/15694

The demand for sarcopenia treatment has increased in North America due to the increasing adoption of nutritional supplements, particularly by the elderly population due to increasing health consciousness. Europe is expected to account second large share in the global sarcopenia treatment market over the forecast period.

The developed European countries, such as Germany, the UK, France, and Italy, are expected to account high share in the Europe sarcopenia treatment market due to increasing sarcopenia prevalence associated with inactive lifestyle and obesity. The Asia Pacific is expected to witness rapid growth in the global sarcopenia treatment market over the forecast period due to increasing aging population in countries such as Japan.

]]>
Be Successful With One And Done Workout Sun, 17 Jan 2021 16:37:44 +0100 http://prwww.comunicati.net/comunicati/istituzioni/regioni/molise/683873.html http://prwww.comunicati.net/comunicati/istituzioni/regioni/molise/683873.html Oughestmor Oughestmor USA (17-01-21) It is a proven fact now that too much weight can make you very uncomfortable and also it can seriously damage your health. Individuals who are suffering from obesity have complex and feel shy in public gatherings which can affect the confidence levels. Data shows that the obesity rates are skyrocketed in past some time. Almost one-third of people have a body mass index higher than normal. Combining exercise with a healthy diet is a very effective way to lose weight than depending on calorie restriction alone. Regular exercises can prevent and even reverse the effects of certain diseases. There are numerous health benefits of doing workouts like it lowers the risks related to blood pressure, cholesterol, cancers, hormonal imbalances, diabetes, and cardiovascular exercises, and so on. Work out is the best way to reduce the effects of anxiety and depression.

 

It enhances all the body functions by regulating the hormonal and endocrine functions in place. The main advantage of exercising is that it burns the calories and fat mass, and increases the muscle mass which provides more strength to the body. The metabolic rate becomes fast which is very helpful in controlling the excess weight gain. There are several gyms and fitness centers that teach workout lessons but in the time of the coronavirus, it is dangerous to get in these public spaces. A lot of online platforms are also giving lessons for losing weight. The one and done workout work out the program is one of a most efficient training program that is aimed to provide short, fast and highly effective workouts. In the one & done workout, each exercise is of 7 minutes and users can take in between breaks for muscle recovery. Individuals can click here and find about the one and done workout meredith shirk by visiting the website.

 

The primary advantage of one and done workout videos is that whether the individual is a beginner or experienced, both can do these exercises very easily by themselves very conveniently at home. The creators of this workout program call it to sprint interval training SIT because individuals gently move the body during the rest positions to allow the body to stay loose and movable. The meredith shirk one and done workouts are available on the official website at very nominal prices. Customers will also get a detailed one & done workout PDF in which all the instructions are mentioned that users should take care of. The main advantages of following this workout routine are more endurance, sleep better, get tighter muscles, improve metabolism, more flexibility and motion, better confidence, and lose weight faster and easier. The whole package will include a 14days workout plan, demo videos, an exercise combination manual, and members-only dashboard for more facilities. In case people have queries about the one and done workouts can click here and visit the website.

 

If necessary, interested people can click here or the official website for full insight One And Done Workout. You can also contact us by providing the information below.

 

Website-: https://www.peninsulaclarion.com/marketplace/one-and-done-workouts-reviews-meredith-shirk-exercise-plans/

]]>
Be Successful With One And Done Workout Sun, 17 Jan 2021 16:37:22 +0100 http://prwww.comunicati.net/comunicati/istituzioni/regioni/molise/683872.html http://prwww.comunicati.net/comunicati/istituzioni/regioni/molise/683872.html Oughestmor Oughestmor USA (17-01-21) It is a proven fact now that too much weight can make you very uncomfortable and also it can seriously damage your health. Individuals who are suffering from obesity have complex and feel shy in public gatherings which can affect the confidence levels. Data shows that the obesity rates are skyrocketed in past some time. Almost one-third of people have a body mass index higher than normal. Combining exercise with a healthy diet is a very effective way to lose weight than depending on calorie restriction alone. Regular exercises can prevent and even reverse the effects of certain diseases. There are numerous health benefits of doing workouts like it lowers the risks related to blood pressure, cholesterol, cancers, hormonal imbalances, diabetes, and cardiovascular exercises, and so on. Work out is the best way to reduce the effects of anxiety and depression.

 

It enhances all the body functions by regulating the hormonal and endocrine functions in place. The main advantage of exercising is that it burns the calories and fat mass, and increases the muscle mass which provides more strength to the body. The metabolic rate becomes fast which is very helpful in controlling the excess weight gain. There are several gyms and fitness centers that teach workout lessons but in the time of the coronavirus, it is dangerous to get in these public spaces. A lot of online platforms are also giving lessons for losing weight. The one and done workout work out the program is one of a most efficient training program that is aimed to provide short, fast and highly effective workouts. In the one & done workout, each exercise is of 7 minutes and users can take in between breaks for muscle recovery. Individuals can click here and find about the one and done workout meredith shirk by visiting the website.

 

The primary advantage of one and done workout videos is that whether the individual is a beginner or experienced, both can do these exercises very easily by themselves very conveniently at home. The creators of this workout program call it to sprint interval training SIT because individuals gently move the body during the rest positions to allow the body to stay loose and movable. The meredith shirk one and done workouts are available on the official website at very nominal prices. Customers will also get a detailed one & done workout PDF in which all the instructions are mentioned that users should take care of. The main advantages of following this workout routine are more endurance, sleep better, get tighter muscles, improve metabolism, more flexibility and motion, better confidence, and lose weight faster and easier. The whole package will include a 14days workout plan, demo videos, an exercise combination manual, and members-only dashboard for more facilities. In case people have queries about the one and done workouts can click here and visit the website.

 

If necessary, interested people can click here or the official website for full insight One And Done Workout. You can also contact us by providing the information below.

 

Website-: https://www.peninsulaclarion.com/marketplace/one-and-done-workouts-reviews-meredith-shirk-exercise-plans/

]]>
Riccione: Arriva il Nuovo Parroco Don Stefano Battarra nella Perla Verde dell’adriatico Sun, 17 Jan 2021 15:55:38 +0100 http://prwww.comunicati.net/comunicati/istituzioni/regioni/emilia_romagna/683869.html http://prwww.comunicati.net/comunicati/istituzioni/regioni/emilia_romagna/683869.html WEBTVSTUDIOS WEBTVSTUDIOS Il Vescovo di Rimini ha nominato don Stefano Battarra, già vicario parrocchiale di San Martino di Riccione, collaboratore della zona pastorale della “Perla Verde” e assistente diocesano di Azione Cattolica Ragazzi (ACR),parroco dei Ss. Angeli Custodi di Riccione http://www.parrocchiaangelicustodi.org/ Video Riccione

Riccione: Arriva il Nuovo Parroco Don Stefano Battarra nella Perla Verde dell’adriatico

 

 

Prende il testimone da don Giorgio Dell’Ospedale, morto il 31 ottobre 2020. Don Stefano (nato a Rimini il 9 settembre 1981), è stato ordinato presbitero, per imposizione delle mani del Vescovo Francesco Lambiasi, il 27 settembre 2015. Attualmente sta conseguendo la Licenza in Teologia sistematica alla Università Gregoriana di Roma: ha già sostenuto tutti gli esami, ed ha in corso una tesi di laurea su Ireneo di Lione. Ama la montagna e le passeggiate in quota, nei boschi e all’aria aperta. Questo avvicendamento, tenendo conto delle caratteristiche della persona, intende favorire la continuità della vita della comunità parrocchiale e il cammino di collaborazione tra le parrocchie della Zona pastorale di Riccione.

“Alla riconoscenza per il servizio svolto dai sacerdoti precedenti, e in particolare di don Giorgio, che alla parrocchia dei Ss. Angeli Custodi ha operato dal 1973 fino al 2020, si aggiunge la gratitudine per la disponibilità offerta da don Stefano, che affidiamo alla materna protezione di Maria, madre dei sacerdoti”.

Di seguito, la Lettera che il Vescovo Francesco invia alla comunità parrocchiale degli Angeli Custodi in occasione dell’avvicendamento del parroco.

“Carissime Sorelle, Carissimi Fratelli tutti, vi raggiungo mentre vi è appena arrivata la buona notizia della nomina del carissimo don Stefano BATTARRA a parroco della vostra bella e amata Comunità. Dopo il ‘santo viaggio’ dell’indimenticabile don Giorgio DELL’OSPEDALE – “servo buono e fedele” che vi ha guidato, sostenuto e fedelmente accompagnato nel cammino della vita cristiana per oltre 50 anni – avete vissuto questi ultimi mesi di amministrazione parrocchiale con il valido aiuto di don Alessio, generosamente coadiuvato dai sacerdoti della città. 

Vengo pertanto a ringraziarvi e a benedirvi con tutto il cuore. Prima ancora benedico la felice memoria di don Giorgio, un ‘prete-prete’, che si è dedicato senza calcoli e senza sconti alla costruzione della vostra Comunità. E l’ha sempre amata con lo slancio esuberante del primo e unico amore, non perché fosse la migliore o esente da limiti e comprensibili difetti umani, ma semplicemente perché è la sposa di Cristo ed è così diventata la sua famiglia: la prima e prediletta. Benedico te, caro don Stefano, per avere accettato con umile, gratuita disponibilità la responsabilità pastorale della parrocchia degli Angeli Custodi. Con le parole di san Paolo sono sicuro che “non farai da padrone sulla fede delle persone, ma da collaboratore della loro gioia” Nutro inoltre fondata fiducia che non considererai l’affidamento della Comunità alla tua cura pastorale né come un peso insopportabile né come un premio ambito e appetibile, ma sempre e solo come un inestimabile dono. Da custodire gelosamente, in stretta comunione con il Vescovo e il presbiterio in Riccione e della diocesi. Da coltivare con cura tenera, appassionata, instancabile. Alla quale dedicarsi anima e corpo, senza riserve e senza condizioni. Sempre e solo per amore del Signore e della sua e nostra Chiesa.

Benedico voi, care Sorelle e Fratelli degli Angeli Custodi, per la limpida testimonianza di comunione fraterna che mi ha davvero edificato. Inoltre vi incoraggio a vivere l’arrivo di don Stefano come una preziosa opportunità per camminare in avanti sulla strada della comunione fraterna tra i sacerdoti, i diaconi e le comunità parrocchiali della ‘zona’ di Riccione, nelle varie forme possibili di corresponsabilità e collaborazione pastorale.

nsieme alle comunità della ‘zona pastorale’, vi auguro di essere lievito di autentica fraternità per tutta la città, a partire dalle periferie urbane ed esistenziali: poveri, malati, quanti sono senza tetto, né lavoro, né pane, o non si sentono amati da nessuno. 

Insieme ai diaconi, ai ministri istituiti e straordinari, alle catechiste e a tutti gli operatori pastorali, ai membri degli organismi di partecipazione parrocchiali e zonali, non stancatevi di contribuire alla creazione di percorsi che favoriscano la comunione, l’attività caritativa, lo slancio missionario. 

Insieme alle donne e agli uomini di buona volontà, in questo momento in cui siamo provati dalla dura pandemia che continua ad affliggerci, mostriamo che ne potremo uscire rinnovati solo se uniti, come un popolo formato da “sorelle e fratelli tutti”. Insieme ci salutiamo e ci benediciamo a vicenda nel nome del Signore. Vostro, di cuore”

Servizi Audiovisivi – Riprese Video – Interviste 
https://www.facebook.com/webtvstudios
http://www.webtvstudios.it

]]>
Meticore Has Lot To Offer In Quick Time Fri, 15 Jan 2021 17:24:21 +0100 http://prwww.comunicati.net/comunicati/istituzioni/regioni/molise/683767.html http://prwww.comunicati.net/comunicati/istituzioni/regioni/molise/683767.html Oughestmor Oughestmor USA (15-01-21) What people eat is the biggest factor in weight loss. People can choose their diets differently, many of the different focus areas like some may have low fat or some may have high protein but in the end, they all aim to reduce the calorie intake. Along with the diet, other important factors are to have good physical activity and regular exercise. These activities allow the brain to secrete some hormones that help to increase the metabolism rate and improve the other body functions. The most important problem that people are facing is that they are not able to follow the strict exercise routine and diet charts given by the dietitians. To solve this problem millions of people are taking dietary supplements for weight loss. These supplements are formulated using all the natural ingredients to avoid side effects. They are rich in nutrients like vitamins, minerals, and other nutrients that fulfill the deficiency of such nutrients.

 

Weight loss supplements increase the metabolic rate in the body and they also suppress food cravings. The body gets detoxified after consuming the natural products. Due to the huge demand for dietary supplements, millions of dietary supplement brands are emerging in the market. People should be sure about the properties and ingredients of these supplements before consuming them. One of the most trustworthy brand weight loss supplements is meticore. The core technology behind this supplement is that it is closely measured by core body temperature. If the core body temperature is high then the metabolism will be more effective weight loss will be maximized. All the ingredients used in meticore free of GMOs, stimulants, preservatives and are 100% vegetarian. This supplement is developed in FDA approved facility. There are several meticore scam available in the market so people should be cautious of such practices. In case of further details, individuals can click here and know more about review of meticore and meticore updates.

 

The main meticore ingredients are Moringa Oleifera, Ginger, African mango, Citrus Bioflavonoids, Fucoxanthin, Vitamin B12, Turmeric Rhizome, Chromium, and so on. These ingredients are either herbs or extracted by the plants. According to a meticore review, the African mango present in the product is very helpful in reducing the appetite. Another advantage is they improve the blood flow and reduce the inflammation in the body. The turmeric extract helps to release dopamine in the body which makes the individuals more happy and motivated, the meticore news suggests. The meticore reviews confirm that there are no meticore complaints recorded so far. This dietary supplement comes with a 60- days money-back guarantee, in which they can return the product. By visiting the site, an individual can get some knowledge about meticore scam complaints faster.

 

If necessary, interested people can click here or the official website for full insight Meticore Reviews. You can also contact us by providing the information below.

 

Website-: https://www.peninsuladailynews.com/marketplace/meticore-review-morning-metabolism-trigger-for-weight-loss/

]]>
The National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies. Fri, 15 Jan 2021 10:59:44 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/abruzzo/683713.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/abruzzo/683713.html Automotive Market Research Reports Automotive Market Research Reports Top impacting factors: Market Scenario Analysis

The ever rising prevalence of several infectious and chronic diseases like cancer, diabetes and arising health problems like depression, stress, lack of sleep and mental disturbance especially in the upcoming generation due to various factors like change in lifestyle is expected to boost the growth of CBD hemp oil market in coming years. Further, the use of hemp oil in numerous forms like spray, tincture and vape especially in the developed and developing economies is one of the major causes that would help the CBD hemp oil market growth. Its wide range of application against diverse diseases and various health benefits related with it such as pain relief, reduction in anxiety and depression, proven benefits when used as a topical ointment for treating skin problems and neuroprotective attributes results in increasing demand for CBD hemp oil all over and is expected to drive the growth of the market.

Due to recent studies and subsequent research of various CBD substances brought to notice the importance of CBD hemp oil in medical industry. In 2017, the National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies.

Companies covered:

Cannavest, Pharmahemp, ENDOCA, BAFA Gmbh, Protect Pharma, Rakitovica, Biobloom Hemp, DragonflyCBD, MH medical hemp GmbH, Elixinol.

According to a report published by World Health Organization, CBD shows no significant results indicative of any abuse or dependence potential. As of now, there is no significant evidence of side effects associated with the use of CBD. Presence of a compound called Delta-9 tetrahydrocannabinol in the oil, is proving significant as it has shown positive outcomes when applied in stress relief and maintaining the body’s general state of balance.

Geographies covered:

  • North America (U.S., Canada, Mexico)
  • Europe (France, Germany, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

However, prohibition for the use of CBD in some countries, the strict regulations regarding use of CBD hemp oil, complex administrative formation for the acceptance of hemp on a large scale and the scarcity of procurement of seeds for agricultural utilization of hemp are some circumstances which can restrain the growth of CBD hemp oil market. In order to overcome these hindrances, the key players in the market are coming up with various innovative solutions and the implementation of these solutions in the current industry scenario along with expansion policies in potential markets in the Asian region can be an important opportunity to grow the CBD hemp oil market.

Key benefits of the report:

  • This study presents the analytical depiction of the global CBD hemp oil industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global CBD hemp oil market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global CBD hemp oil market growth scenario.

North America Emerges as the Largest Market for CBD Hemp Oil

Legalization of marijuana countries like the United States, increasing usage due to rising awareness of the health benefits of CBD Hemp oil, North American region is predicted to have immense growth with highest market share in the global market. The presence of industry players in the region is also having a promising impact on the market growth. Furthermore, the heavy funding for R&D activities and well-developed healthcare infrastructure are fueling the market growth for CBD hemp oil.

]]>
The Flavors Into Over The Counter OTC Pharmaceuticals Market To Be Resplendent At A CAGR Of 7% Fri, 15 Jan 2021 08:54:33 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683684.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683684.html persistencemarketresearch persistencemarketresearch Preference for fruit flavors in medicines is an ongoing trend in the  flavors into over-the-counter (OTC) pharmaceuticals market . The consumption of fruit flavor formulations by leading manufacturers is relatively high as compared to other flavors.

Strong consumer preference for fruit flavors has prompted manufacturers of OTC pharmaceuticals to develop unique formulations using them.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/30665

Company Profiles:

  • Givaudan SA
  • International Flavors & Fragrances Inc.
  • Kerry Group
  • Sensient Technologies Corp.
  • GOLD COAST INGREDIENTS, INC.
  • Prinova Group LLC.
  • Carmi Flavor and Fragrance Co. Inc.
  • AromataGroup srl
  • Marc Flavors
  • Quest Nutra Pharmaceuticals
  • Sapphire Flavors & Fragrances
  • TASTE MASTER FLAVORS PVT LTD.
  • Virginia Dare
  • Concept Flavours & Fragrances Pvt. Ltd.
  • Flavor & Fragrance Specialties

Fruit flavors such as pineapple, strawberry, cherry and orange are mostly preferred flavors for pharmaceuticals. The adoption of flavored pharmaceuticals, especially in medicines for kids, is increasing because of the taste masking effect of these medicines.

Citrus and lemon flavors, followed by fruit flavors, are commonly used by formulators of pharmaceuticals.

Lemon and mint flavors are generally preferred in chewable tablets or gums. Vanilla or other dairy-based flavors are the least preferred flavors, used in medicines.

PMR has also found that the adoption of flavored medicines, among geriatric patients is lesser as compared to those for pediatric patients.

Outsourcing and Industrial Consolidation – Key Winning Imperatives

The report states that the companies manufacturing OTC pharmaceuticals typically focus on volume, and hence have been shown to be involved in several industrial collaborations. Key players in the flavors into over-the-counter (OTC) pharmaceuticals market are focusing on entering into strategic collaborations and acquisitions of companies operating in related industry to strengthen their position and extend their global reach.

For Example, in 2018, Sensient Technologies Corp. completed the acquisition of Mazza Innovation Limited, a botanical extraction business with patented solvent-free extraction processes, located in Vancouver, Canada.

Similarly, in 2017, International Flavors & Fragrances Inc. acquired “David Michael”, a privately held flavor company. Through this acquisition, International Flavors & Fragrances, Inc. strengthened its flavor market position in North America.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/30665

Tapping into Opportunities in Developing Countries

Most of the pharmaceutical players are focusing on developing markets, due to the stagnation of the major markets and presence of a large number of local manufacturers, especially in developing countries.

Changes in disease pattern caused due to changes in the lifestyle, increase in disposable income, improved access to healthcare services, and increasing demand for high-quality healthcare make these markets highly profitable for pharmaceutical companies.

However, this trend is currently opposite in developed economies with sophisticated manufacturing practices, where demand for superior quality excipients is increasing.

An increase in the adoption of continuous processing of excipients, is also an ongoing trend in flavors into the over-the-counter (OTC) pharmaceuticals market. Continuous processing of excipients refers to flow production of the raw material without any kind of interruption.

Manufacturers Target towards Production Capacity Expansion

Over the past few years, major pharmaceutical companies have been expanding their external and internal capacity in production.

Outsourcing opportunities arise in all innovator, generic, as well as other markets for OTC medications.

Even though manufacturing technologies for OTC medications have rapidly matured in the past two decades, the manufacturing of low-margin OTC generics requires the usage of old technologies.

While major pharmaceutical companies are investing resources on newer technologies, the manufacturing of generic OTC drugs and branded over-the-counter drugs is being outsourced.

South Asia & East Asia Remain Prominent Markets

South Asia and East Asia are expected to show significant growth of the flavors in over-the-counter (OTC) pharmaceuticals market. A large portion of the population of Asia remains undertreated, majorly due to the unavailability of effective prescribed drugs, and this is providing growth opportunities for the flavors into over-the-counter (OTC) pharmaceuticals market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/30665

Low Awareness and Poor Availability of OTC Drugs to Hinder the Market Growth

Lack of awareness about the flavors into OTC pharmaceuticals, especially in the developing economies, continues to create a hindrance in the market growth.

Poor availability of drugs at hospital pharmacies and retail pharmacies can be responsible for decreasing the overall growth of the flavors into over-the-counter (OTC) pharmaceuticals market. Also, the marketing of OTC pharmaceutical products requires skilled, trained and knowledgeable pharmacists. A lack of skilled and trained pharmacists, especially in the developing regions, can hinder the overall growth of the flavors into over-the-counter (OTC) pharmaceuticals market.

]]>
The Global Scar Treatment Market To Grow At A Splendid CAGR Of 3% Fri, 15 Jan 2021 08:54:10 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683683.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683683.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR) reveals that revenue generated from scar treatment product during financial year 2019 is approximately more  than US $ 10 Bn . According to the report published by PMR, reveals that the  scar treatment market  is anticipated to  show 1.4X growth  over the next decade owing to greater preference towards usage of specialized dermatology services.

This report by PMR points to the lack of standardization in the scar treatment landscape. The study reveals that there are no formalized guidelines for scar treatment, and most of them are recommended through word-of-mouth of expert clinicians and surgeons. However, efforts for the formalization of treatment guidelines, at least for common scars, still continue.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10819

Company Profiles:

  • Smith & Nephew PLC
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

Rising Awareness about Personal Care Propelling the Demand

Scars, especially those on exposed parts of the body can adversely affect the appearance and may let down the self- confidence and consciousness of an individual. Consumers in the U.S. are more inclined towards new sophisticated scar treatment, such as lasers skin resurfacing, electrical stimulation, and derma fillers to maintain and further reduce scar appearance.

Expert plastic surgeons opine that a significant share of the population in the U.S., primarily within the age group of 18-30 years and onwards, is increasingly resorting to advanced skin, scar, and dermatology services, thus, creating sufficient traction for scar treatment product manufacturers.

Rising awareness about personal care and wide availability of rhytides treatment and related products are among the major factors driving growth of the scar treatment market in North America and Europe.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/10819

Patients Seek Quicker Results and Shortened Treatment Duration

Patients opting for scar treatment are increasingly adopting technologically advanced non-invasive or minimally invasive scar treatment procedures for achieving quicker and permanent results in a short time. To address this issue, physicians are gradually seeking more patient-involvement in the scar treatment formulation process.

For example, in developed countries, physicians prefer to explain the indication / s and different scar treatments that could help in curing them - to patients on the very first consultation appointment.

For example, a combination of inflammatory and non-inflammatory acne pimples could be best-cured using two topical medications - a retinoid and an antibiotic, an option for scar treatment. Managing patient expectation is a crucial attribute on part of both physicians and companies to deepen revenues.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/10819

Increasing Patient Involvement in Treatment Formulation Process

With heightened focus towards increasing patient safety and treatment efficacy, an increasing number of dermatologists in both the US and Canada are involving patient's opinion in the scar treatment formulation process.

This is being particularly noted for patients aged 13–25 years (teens to late teens), particularly for mild to deep acne scarring. In this regard collected, scar treatment adherence data over a period of 30 years from Global Alliance to Improve Outcomes in Acne Group reflected poor results while managing the acne regimen.

Deviations noted include self-medication, missing doctor appointment schedules, or both. These were directly a result of combination of multiple factors, including demographics, lifestyle, psychological / psychiatric issues, and environment.

Given these issues, physicians and clinicians have noted that greater patient involvement in therapeutic planning process along with increasing awareness of patients by imparting proper training have been proving highly effective with regard to positive outcomes for scar treatment.

]]>
The Urinary Catheters Market To Leave Behind Presumptions With An Estimated CAGR Of 4.1% Fri, 15 Jan 2021 08:53:48 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683682.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683682.html persistencemarketresearch persistencemarketresearch Global revenue of urinary catheters reached ~  1.5 billion  in 2018, unveils the new research study by Persistence Market Research (PMR). According to the report,  the urinary catheters market  is estimated to grow  by ~ 4% YOY in 2019 , primarily attributed to ease of use, cost effective nature, reduced risk of urinary tract infection, and increase in demand as it is an effective solution among patient population.

Intermittent urinary catheter is gaining a great deal of footing in the market, as intermittent catheterization remains the first and safer method of choice. This urinary catheter does not have many contraindications and permits typical bladder elements. The single-use intermittent urinary catheter is most favored for intermittent catheterization, as it is advantageous and further brings down the risk of long and transient entanglements.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc.
  • Hollister Incorporate
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

According to the report, increasing focus on advanced urinary catheters coated with hydrogel, teflon, silicon, elastomer, etc., is rising owing to increasing concern of regulatory bodies across all regions to reduce the infection during catheterization process.

Demand for Intermittent Urinary Catheters to Create Opportunities for Key Market Players

According to the PMR report, intermittent urinary catheters are likely to dominate the urinary catheters market during forecasted period, as these catheters are widely used for an effective bladder management strategy for patients with incomplete bladder emptying, due to idiopathic or neurogenic detrusor overactivity.

Urinary catheter sales are set to see an uptick, as they are relatively easy to use with just a simple procedure and can be used temporarily after certain types of surgery of prostate, genitals, or after an abdominal hysterectomy. Indwelling urinary catheters referred as “Foley” is a closed sterile system with catheters and balloon as external devices for collection of urine.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3268

The indwelling urinary catheters segment is expected to grow in the forecasted period at a CAGR ~3%, owing to its usage only for short duration, defined as less than 30 days (EAUN recommends no longer than 14 days).

Demand for urinary catheters increases with increase in application in various indications namely, urinary incontinence, urinary retention, prostate gland surgery, and spinal cord surgery.

Application for urinary catheters in prostate gland surgery will continue to account for greater sales, and it is estimated to shoot up by the end of 2029, due to increasing prevalence of benign prostatic hyperplasia (BPH) and prostate cancer. High application potential is also identified in urinary incontinence, due to its increasing prevalence among women population worldwide.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3268

Investments in Asia Representing Scope for Future Market Growth

A large proportion of the geriatric population aged 65 or above across the globe suffer from urinary disorders, such as urinary retention and incontinence. The elderly population in developed regions such as North America, and Europe is increasingly using urinary catheters.

In contrast, urinary catheter usage penetration is relatively low in developing regions such as in Asia and Latin America, which represents scope of further penetration of urinary catheters in these regions.

Additionally, increasing healthcare spending and growing awareness among physicians and patients in developing Asian countries are expected to result in major opportunities for key players in the global market.

A research study by Persistence Market Research (PMR) analyzed that the Asian market for urinary catheters is expected to grow by CAGR ~ 4%. Accounting for ~ 23%  share, the Asian market opens new opportunities for key players to expand their footprint in the region, in the view of improved healthcare facilities and growing healthcare expenditure per capita.

]]>
The Pyrogen Testing Market To Take A Parabolic Turn With A CAGR Of 9% Fri, 15 Jan 2021 08:53:26 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683681.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683681.html persistencemarketresearch persistencemarketresearch The new market intelligence report by Persistence Market Research (PMR) reveals that the  global pyrogen testing market  will  reach US $ ~ 800 Mn  by the end of 2019, and further exhibit a  robust CAGR of 9%  through the next decade.

The increasing trend of outsourcing drug manufacturing to low-cost production regions by most pharmaceutical companies has been touted to remain a major influencer associated with the growth of pyrogen testing market landscape over the period of assessment, as it allows for low-cost skilled workforce and ease in tax relaxation.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/4259

Company Profiles:

  • Thermo Fisher Scientific, Inc.
  • Merck & Co., Inc.
  • Associates of Cape Cod, Inc.
  • Charles River Laboratories, Inc.
  • GenScript
  • Lonza
  • Hyglos GmbH
  • Wako Chemicals USA, Inc.
  • Microcoat Biotechnologie GmbH

Growing Number of Pharmaceutical and Biotechnology Companies to Bring Traction to Pyrogen Testing

As medical devices cross the barriers within the body leading to contamination, pyrogen testing could be used by healthcare professionals to detect the harmful substances present in those devices. In addition, growing healthcare awareness also leads to upsurge in the medicine demand, which increases establishment of pharmaceuticals and biotechnology industries.

This in turn, propels the demand for pyrogen testing in these establishments worldwide. Moreover, increase in number of people diagnosed with various diseases results in the rising demand for various injectables, vaccines, tablets, and other medicines in turn, fueling the demand for safety measures such as pyrogen testing.

According to the PMR analysis, in end user, pharmaceutical companies will dominate the demand side in the pyrogen testing market by the end of 2019 and will also continue to exploit the highest share in the forecast period.

This is due to the growing number of pharmaceutical establishments in developed as well as developing countries, which increases the need for drug safety checks like pyrogen testing.

Demand for limulus amebocyte lysate (LAL) pyrogen testing is estimated to grow by the end of 2029, as end users demands for user-friendly pyrogen testing method that are cost-effective, and incur low equipment cost as well. Thus, the PMR study report estimates that LAL pyrogen testing method will harness around 60% of the global pyrogen testing market share during the forecast period.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4259

Favorable Government Initiatives to Augur Well for Pyrogen Testing Market

Increasing spending by government bodies to develop effective drugs and medical devices is expected to drive the growth of the global pyrogen testing market in the forecast period. Pyrogen is a prominent cause that leads to shock or fatality among a large section of the patient population creating an economic burden on the country.

Thus, increasing healthcare spending is expected to result in growing demand for pyrogen testing by various pharmaceutical and medical device companies. Also, government in various countries are focused on of infectious diseases to reduce associated healthcare costs, which in turn prevention is expected to result in high demand for healthcare facilities.

In order to further complement this, government is focusing on pyrogen testing policies for contaminant-free medical devices and pharmaceuticals provided to the patient population, which will pave the way for the elevated requirement of pyrogen testing in the market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/4259

Hence, companies operating in the pyrogen testing market are expected to largely benefit from such developments.

PMR's analysis also projects groundbreaking perspectives on the competitive business scenario of the pyrogen testing market along with highlights of participants' key business policies and approaches.

For instance, many drug manufacturing units are investing in foreign nations, especially in emerging economies of Asia Pacific and Latin America, which hold great future opportunities for the pyrogen testing market. Various pharmaceutical and medical device manufacturers are establishing their manufacturing base in India, China, and others in order to tap and cater to the unmet needs of the patient population in these regions, thus escalating the market for pyrogen testing.

]]>
The Ultrasonic Skin Care Devices Market To Grow Organically At A CAGR Of 5% Fri, 15 Jan 2021 08:53:04 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683680.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683680.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR) published a report on the ultrasonic skin care devices market, which considers the global industry analysis 2014 - 2018 and opportunity assessment 2019 - 2029, and projects that  the ultrasonic skin care devices market  is expected to reach ~  US $ 440 Mn  by the end of 2019 in terms of value, and is forecasted to reach ~  US $ 720 Mn  by the end of 2029.

The presence of large number of companies is creating a healthy environment among the players. Companies with wide range of ultrasonic skin care devices are creating competitive environment for the other players in the market. The players are constantly working on developing better products to stay ahead of the pack.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/27490

Company Profiles:

  • Merz Pharma GmbH & Co. kGaA
  • Koninklijke Philips N.V
  • Iskra Medical d.o.o
  • Ibramed
  • Shenzhen Leaflife Technology Co., Ltd
  • Guangzhou Beautylife Electronic Technology Co., Ltd.
  • Ionto Health & Beauty Gmbh
  • Grand Aespio Inc.
  • Termosalud S.L
  • Adore cosmetics
  • Hironic Co. Ltd.
  • Bomtech Electronics co., Ltd
  • General Project Srl
  • Asterasys Co. Ltd.
  • Jellen Products Inc.

Companies such as Merz Pharma GmbH & Co. KGaA, Adore Cosmetics, Jellen Products, Inc. etc. are some of the prominent players in the market. Presence of local players including Shenzhen Bowei tech Co.ltd, Zerone Co., Ltd., and others are further likely to challenge the established companies.

Thus, these conditions are inciting manufacturers to come up with more advanced and improvised ultrasonic skin care devices.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/27490

Manufacturers to Tap Opportunities in Sales through E-commerce Sites

The online availability of the ultrasonic skin care devices has created a favorable condition for the market players. Most of the companies provide the international shipping services, and therefore the devices can be ordered from anywhere globally.

Many products are also available on online shopping sites such as amazon, flipkart, etc. and can be easily purchased by consumers, even in remote areas. These online websites also help in brand promotion and advertisement of ultrasonic skin care devices, thereby creating better opportunities for players.

Increasing Adoption of Home-based Skin Care Devices to Push the Market Growth

There is high demand for home care setting ultrasonic skin care devices which are user friendly and convenient to use. These ultrasonic skin care devices are cost effective and do not require any extra maintenance. Also, the procedure time for home care ultrasonic skin care devices are shorter as compared to table top devices and do not require professionals to operate.

Products such as palm sonic by Adore Cosmetics, Visa boost by Philips, PureCle Dr. by Bomtech Electronics co., Ltd. continue to account major share of the manufacturers' bottom lines. Home- based devices are easy to handle and do not require any professional assistance. These devices can be used for various applications such as skin tightening and skin rejuvenation, with better results.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/27490

Table top devices are used in hospitals and clinics, and require professional experts to operate them. The ultrasonic skin care tabletop devices are widely used to overcome several skin related problems and to perform certain procedures like face lifting, skin tightening etc.

However, the cost of these ultrasonic skin care devices are high as compared to other handheld devices, thus representing a threat to the market growth. For instance, Ultherapy ultrasonic device manufactured by Merz Pharma GmbH & Co. KGaA are widely used in aesthetic clinics and has average price of  US $ 70000 . Such high cost of these devices are likely to act as a hindrance for the growth of the ultrasonic skin care devices market.

]]>
The Pulmonary Fibrosis Treatment Market To Witness A Steep CAGR Of Double In% Fri, 15 Jan 2021 08:52:42 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683679.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683679.html persistencemarketresearch persistencemarketresearch Globally, increasing diagnosis rate for the pulmonary fibrosis is expected to drive the growth of the pulmonary fibrosis treatment market. According to the latest research by the company, the  global pulmonary fibrosis treatment market  is projected to account for a market value of  ~ US $ 4.4 Bn by the end of 2029 . The report also projects significant growth potential for the pulmonary fibrosis treatment market throughout the forecast period.

Increasing diagnosis rate of the pulmonary fibrosis due to enhanced understanding of the disease is the prime driver of the pulmonary fibrosis treatment market. Although the disease understanding and understanding of the associated symptoms has advanced immensely, misdiagnosis still remains as high as 40% in developed regions, potentially hampering the growth of the pulmonary fibrosis treatment market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/30070

Company Profiles:

  • Genentech, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Alkem Laboratories Ltd.
  • Alniche Life Sciences Pvt Ltd
  • MHS Pharmaceuticals
  • Torrent Pharmaceuticals Ltd
  • Anthem Biopharma Pvt Ltd
  • Panacea Biotec
  • Zydus Healthcare Ltd
  • Nuper Therapeutics
  • Fresenius Kabi India Pvt Ltd.
  • Sun Pharmaceutical Industries Ltd

Increasing literature about the pulmonary fibrosis treatment, causes and increasing small and medium sized regional studies by universities, pulmonary fibrosis organizations are assisting to improve the overall awareness about the disease in the general population.

The similarities of symptoms of pulmonary fibrosis with other respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, etc. are the major impediments in the precise diagnosis of the disease delaying the pulmonary fibrosis treatment.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/30070

Combination Drug Therapies

Corticosteroids, coupled with immunosuppressants and chemotherapeutic agents, were the only treatment available for the pulmonary fibrosis till the drugs such fibrosis Ofev (nintedanib) and Esbriet (pirfenidone) approved for the pulmonary fibrosis treatment in 2014. 

Both drugs slow disease progression by slowing down the lung tissue scarring. Patients treated with monotherapy of these drugs or combination therapy of these drugs along with corticosteroids or immunosuppressants has given healthcare professionals pulmonary fibrosis treatment options for the effective management of the disease.

Various new therapies are being evaluated by pharmaceutical and biopharmaceutical companies for the possible pulmonary fibrosis treatment.

Orphan drug designation reduces drug development cost considerably in turn encouraging pharmaceutical and biopharmaceutical companies to develop drugs for the treatment of rare diseases such as pulmonary fibrosis. Companies that received the orphan drug designation for their products for pulmonary fibrosis treatment benefitted from protocol assistance, marketing authorization, financial incentives, and national incentives provided by the European Commission.

The FDA orphan drug designation programs offer a unique status to biologics and drugs intended to pulmonary fibrosis treatment, diagnose, and prevent diseases in the US The FDA orphan drug designation offers an exclusivity period of seven-year marketing for competition and certain incentives including tax credits , federal grants, and a waiver of PDUFA filing fees .

Access Full Report @  https://www.persistencemarketresearch.com/checkout/30070

In August 2019 , Daewoong Pharmaceutical received orphan drug designation from UFDA for its DWN12088, oral IPF therapy.

The company has segmented the global pulmonary fibrosis treatment market based on the therapy type, indication, distribution channel, and region. In terms of revenue, the monotherapy segment by therapy type is expected to be a prominent segment in pulmonary fibrosis treatment market over the forecast period.

By indication, the idiopathic pulmonary fibrosis (IPF) segment of the pulmonary fibrosis treatment market is expected to generate highest revenue during the forecast period due to higher prevalence of the disease type. By distribution channel, the pulmonary fibrosis treatment market is expected to be dominated by the retail sales segment due to higher patient footfall.

By region, the North America pulmonary fibrosis treatment market is expected to be a prominent region in the global pulmonary fibrosis treatment market.

]]>
CS Rebibbia Thu, 14 Jan 2021 16:01:54 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/683625.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/683625.html assotutela assotutela
 

Mail priva di virus. www.avast.com
]]>
Bronchitis Market is a leading cause of death in the U.S. affecting 16million Americans Thu, 14 Jan 2021 12:10:11 +0100 http://prwww.comunicati.net/comunicati/istituzioni/camere_di_commercio/683576.html http://prwww.comunicati.net/comunicati/istituzioni/camere_di_commercio/683576.html Automotive Market Research Reports Automotive Market Research Reports The common pathogens causing bronchitis are respiratory syncytial virus, Influenza virus A and B, Parainfluenza, rhinovirus, and similar viruses. For the people with smoking habits and people involved in passive inhalation, both along with the ones having history in respiratory diseases such as asthma, cystic fibrosis, or bronchiectasis have a higher chance of developing chronic bronchitis. Exposure to toxic chemicals, pollutants such as ammonia and sulfur dioxide have a higher risk of developing chronic bronchitis. Often it is observed that, people having allergy problems to pollens, dusts also develop acute bronchitis.

Companies covered:

  • Melinta Therapeutics
  • Boehringer Ingelheim
  • Dr. Reddy’s Laboratories Ltd
  • GlaxoSmithKline Pharmaceuticals Limited
  • Pfizer Inc.
  • Sanofi Aventis
  • AstraZeneca plc.
  • Novartis AG.

Regions covered:

  • North America (U.S., Canada, Mexico)
  • Europe (France, Germany, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

Rising cases of bronchitis and therapeutic treatments to favor market growth in North America

Bronchitis Market is a leading cause of death in the U.S. affecting 16million Americans. The American Lung Association goes further by stating as many as 24 million Americans were affected due to various lung impairments, with bronchitis affecting majority of the population among them in 2016. In U.S., women have a chronic bronchitis at almost double rate of men with 5.9 million women had been diagnosed with chronic bronchitis in past 12 months. North American region is expected to grow due to factors like rising incidence of bronchitis and an increasing habits of chain-smoking in the present generation. In the region, the United States holds the largest bronchitis treatment market share due to factors such as a growing number of geriatric populations, along with an increasing number of diseases as well as healthcare spending in the country and the availability of advanced healthcare infrastructure are few of the factors, which is anticipated to stimulate the demand in this region. 

Key benefits of the report:

  • This study presents the analytical depiction of the global bronchitis treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global bronchitis treatment market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global bronchitis treatment market growth scenario.
]]>